|Traded as||OMX: ORNBV|
|Key people||Timo Lappalainen (President and CEO), Hannu Syrjänen (Chairman)|
|Products||Pharmaceuticals, active pharmaceutical ingredients and diagnostic tests|
|Revenue||€980.4 million (2012)|
|Operating income||€280.9 million (2012)|
|Profit||€208.9 million (2012)|
|Total assets||€836.9 million (end 2012)|
|Total equity||€511.3 million (end 2012)|
|Employees||3,486 (average, 2012)|
Orion Corporation, founded in 1917 and headquartered at Espoo, Finland, is a Finnish company, which develops, manufactures and markets pharmaceuticals, active pharmaceutical ingredients and diagnostic tests for global markets. The company also has a large R&D unit in Turku.
- "Annual Results 2012". Orion. Retrieved 22 March 2013.